Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Asset Utilization Ratio (2021 - 2025)

Caribou Biosciences (CRBU) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.04 as the latest value for Q2 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 56.57% to 0.04 in Q2 2025 year-over-year; TTM through Jun 2025 was 0.04, a 56.57% decrease, with the full-year FY2024 number at 0.03, down 68.66% from a year prior.
  • Asset Utilization Ratio was 0.04 for Q2 2025 at Caribou Biosciences, up from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q3 2023 to a low of 0.02 in Q4 2021.
  • A 5-year average of 0.05 and a median of 0.04 in 2025 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: surged 176.53% in 2023, then plummeted 57.56% in 2025.
  • Caribou Biosciences' Asset Utilization Ratio stood at 0.02 in 2021, then soared by 68.92% to 0.04 in 2022, then surged by 116.14% to 0.08 in 2023, then grew by 9.59% to 0.08 in 2024, then plummeted by 56.57% to 0.04 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Asset Utilization Ratio are 0.04 (Q2 2025), 0.03 (Q1 2025), and 0.08 (Q2 2024).